ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1247

Features of Childhood Sjogren’s Syndrome: A Literature Review Based Cohort

Achille Marino1, Micol Romano2, Teresa Giani3, Carla Gaggiano4, Stefania Costi5, Revika Singh6, Jay Mehta7, Scott Lieberman8 and Rolando Cimaz9, 1Department of Pediatrics, Desio Hospital, Milan, 2ASST Gaetano Pini-CTO Institute, Milan, Italy, Milan, Italy, 3AOU Meyer, Florence, Italy, 4Department of Pediatrics, University of Siena, Siena, Italy, Siena, Italy, 5University of Milan, Milan, Italy, Milan, Italy, 6Northwestern University, Evanston, IL, 7Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, USA, Philadelphia, PA, 8Department of Pediatrics, University of Iowa, Iowa City, US, Iowa City, IA, 9ASST Gaetano Pini-CTO Institute and Università degli Studi di Milano, Milan, Italy, Milan, Italy

Meeting: ACR Convergence 2020

Keywords: Pediatric rheumatology, Sjögren's Syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Sjögren’s Syndrome Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Sjogren’s syndrome (SS) is an autoimmune chronic disease characterized by inflammation of exocrine glands, but it can affect other organs as well.This study aims to describe childhood SS (cSS) features by reviewing pediatric published cases with individual data.

Methods: We conducted a literature review of cSS (age < 18 years). Eligible papers were identified through a Medline search of English language articles published in the PubMed database until February 2020. Statistical analysis was performed to detect associations between clinical/laboratory features.

Results: Two-hundred-forty patients were identified (191 female); the median age at disease onset was 10 years (range3 months-17 years). Main clinical features are shown in Figure 1. The most frequently reported clinical SS-specific feature was parotitis (134/198 patients; bilateral:unilateral=2.5:1); fewer patients had sicca symptoms (89/159 with dry eyes; 85/144 with dry mouth). Arthritis was the most frequent extraglandular manifestation. Renal tubular acidosis represented the typical expression of renal involvement (19 cases). Neuromyelitis optica and aseptic meningoencephalitis (6 and 9 cases, respectively) were the most typical neurologic manifestations. Two cases of interstitial lung disease and one of pulmonary hypertension were reported. Investigations are shown in Figure 2. Almost all patients had autoantibodies, mostly ANA (200/224 patients) and anti- SSA/Ro (170/208 patients). The Schirmer test was performed in less than half of the patients, of whom 62% tested positive. A positive result of minor salivary biopsy was reported in 129/140 cases with available data. Juvenile idiopathic arthritis was the most frequently associated disease, followed by systemic lupus erythematosus (16 and 8 cases, respectively). No significant differences between patients with or without parotitis were found except that patients with parotitis showed increased levels of CRP more frequently than those without it (p= 0.00). Patients with anti-SSA/Ro had more frequently a positive Schirmer test (p= 0.04). The presence of RF was significantly associated with dry mouth (p= 0.00), arthritis (p= 0.00), and rash (p= 0.04). A positive minor salivary biopsy was more common in children with dry eyes than in those without this clinical feature (p= 0.02). Arthritis was more frequent in patients with other diseases than in those with primary SS (p= 0.00). We further investigated SS features according to the age groups (≤ 6 years, 7-11 years, ≥ 12 years). Parotid involvement was inversely proportional to the age and occurred more frequently in younger patients (79% of those ≤ 6 years; p= 0.03). Interestingly, the rate of anti-SSA/Ro positivity increased with age (97% of those ≥ 12 years; p= 0.00).

Conclusion: Even though parotitis was the most frequently reported feature, a wide range of clinical manifestations in children with SS has been reported so far. A better knowledge of cSS features will help to pave the way for the development of cSS specific diagnostic criteria.

Figure 1. Main clinical features. *Values are the number of patients with positive findings/patients with available information (%). CNS: central nervous system

Figure 2. Investigations. *Values are the number of patients with positive findings/patients with available information (%). CRP :C-reactive protein; ESR: erythrocyte sedimentation rate; RF: rheumatoid factor; ANA: antinuclear antibodies; Opthalm test: Ophthalmological test (Schirmer test or Rose Bengal staining); MSG biopsy: minor salivary gland biopsy.Imaging: parotid ultrasound or computed tomography, sialogram, scintigraphy


Disclosure: A. Marino, None; M. Romano, None; T. Giani, None; C. Gaggiano, None; S. Costi, None; R. Singh, None; J. Mehta, None; S. Lieberman, None; R. Cimaz, None.

To cite this abstract in AMA style:

Marino A, Romano M, Giani T, Gaggiano C, Costi S, Singh R, Mehta J, Lieberman S, Cimaz R. Features of Childhood Sjogren’s Syndrome: A Literature Review Based Cohort [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/features-of-childhood-sjogrens-syndrome-a-literature-review-based-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/features-of-childhood-sjogrens-syndrome-a-literature-review-based-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology